Daewoong Pharma (069620) — Net Asset Momentum
Daewoong Pharma (069620) recorded a net asset momentum of 15.4% as of December 2024, with net assets of ₩926.98 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 069620 net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Daewoong Pharma Net Asset Momentum (2007–2024)
This chart tracks Daewoong Pharma's year-over-year net asset growth across 16 annual reporting periods from 2007 to 2024. The most recent momentum reading is +15.4%, with net assets of ₩926.98 Billion KRW as of December 2024. For live market cap and overall valuation, see 069620 stock market capitalisation.
Annual Net Asset History for Daewoong Pharma (2007–2024)
The table below shows the complete annual net asset history for Daewoong Pharma from 2007 to 2024, covering 16 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Daewoong Pharma (069620) tangible equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩926.98 Billion | ₩1.98 Trillion | ₩1.05 Trillion | ▲ +15.4% |
| 2023 | ₩802.97 Billion | ₩1.57 Trillion | ₩762.77 Billion | ▲ +8.3% |
| 2022 | ₩741.22 Billion | ₩1.56 Trillion | ₩822.12 Billion | ▲ +5.5% |
| 2021 | ₩702.41 Billion | ₩1.42 Trillion | ₩712.77 Billion | ▲ +1.0% |
| 2020 | ₩695.25 Billion | ₩1.37 Trillion | ₩671.66 Billion | ▲ +9.3% |
| 2019 | ₩635.92 Billion | ₩1.25 Trillion | ₩609.75 Billion | ▲ +4.6% |
| 2018 | ₩607.81 Billion | ₩1.21 Trillion | ₩600.04 Billion | ▼ -3.8% |
| 2017 | ₩631.54 Billion | ₩1.21 Trillion | ₩581.99 Billion | ▲ +4.5% |
| 2016 | ₩604.55 Billion | ₩1.14 Trillion | ₩540.15 Billion | ▲ +4.2% |
| 2015 | ₩580.24 Billion | ₩944.53 Billion | ₩364.29 Billion | ▲ +27.4% |
| 2014 | ₩455.51 Billion | ₩694.26 Billion | ₩238.76 Billion | ▲ +4.0% |
| 2013 | ₩437.96 Billion | ₩579.01 Billion | ₩141.05 Billion | ▲ +13.3% |
| 2012 | ₩386.59 Billion | ₩482.34 Billion | ₩95.76 Billion | ▲ +6.7% |
| 2011 | ₩362.42 Billion | ₩498.46 Billion | ₩136.04 Billion | ▲ +30.0% |
| 2008 | ₩278.85 Billion | ₩486.24 Billion | ₩207.39 Billion | ▲ +3.4% |
| 2007 | ₩269.57 Billion | ₩392.81 Billion | ₩123.24 Billion | — |